NATIONAL ACADEMY of SCIENCES Volume 31 December 15

Total Page:16

File Type:pdf, Size:1020Kb

NATIONAL ACADEMY of SCIENCES Volume 31 December 15 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES Volume 31 December 15. 1945 Number 12 Copyright 1946 by the National Academy of Sciences THE SYNTHESIS OF BUTYRIC AND CAPROIC ACIDS FROM ETHANOL AND ACETIC ACID BY CLOSTRIDIUM KLUYVERI By H. A. BARKER, M. D. KAMEN* AND B. T. BORNSTEIN DIVISION OF PLANT NUTRITION, UNIVERSITY OF CALIFORNIA Communicated October 29, 1945 Unpublished investigations in this labora.tory have shown that Clostrid- ium kluyveri can metabolize acetic acid and ethanol under anaerobic con- ditions producing butyric and caproic acids in accordance with equations (1) and (2). CH3CH20H + CH3COOH = CH3CH2CH2COOH + H20 (1) 2CH3CH20H + CH3COOH = CH3(CH2)4COOH + 2H20 (2) The relative yields of the two acids are determined by the relative amounts of acetic acid and ethanol available. If acetic acid is present in excess, a considerable amount of butyric acid is formed, while if ethanol is in excess, caproic acid is the main product. These relations suggest that butyric acid may be an intermediate in the synthesis of caproic acid from acetic acid. This is supported by the observation that ethanol and butyric acid can be converted to caproic acid according to equation (3). CH3CH2OH + CH3CH2CH2COOH = CH3(CH2)4COOH + H20 (3) In the present investigation we have obtained positive proof for the con- version of acetic acid to caproic acid via butyric acid by studying the action of Cl. kluyveri on media containing synthetic fatty acids labeled with the long-lived radioactive carbon isotope C14. In addition we have obtained various types of evidence which help to elucidate the mechanism of fatty acid synthesis from C2 molecules. Experimental Methods.'-Carboxyl-labeled acetic, butyric and caproic acids were prepared from C*02 and methyl iodide, propyl bromide and amyl bromide, respectively, by the Grignard synthesis.1 The general technique of estimating the C14 content of carbon dioxide and fatty acids has already been described elsewhere.2 The barium salts Downloaded by guest on September 25, 2021 374 BA CTERIOLOG Y: BARKER, ET AL. PROC. N. A. S. of the fatty acids dried at 100°C. were used in the radio-assay. The indi- vidual acids were separated from mixtures by the distillation procedure of Schicktanz, et al,' The purity of each acid was established by Duclaux distillation. The methods used in locating C'4 in the individual carbon atoms of acetic and butyric acids have been described previously.2' 4, 5 The occurrence of C14 in the carboxyl group of caproic acid was deter- mined by decarboxylating the barium salt. Control experiments with syn- thetic caproic acid showed that this method yields 52 per cent of the. car- boxyl carbon as barium carbonate. The bacteria were grown in media of the following composition in g. per 100 ml.: ethanol 0.3-0.8, sodium salt of labeled acetic or butyric acid 0.3-0.6, yeast autolysate 0.3, pH 7.2, phosphate buffer M/40, (NH4)2SO4 0.1, MgSO4-7H200.01, FeSO4.7H20 0.0001, sodium thioglycollate 0.05, TABLE 1 THE FERMENTATION OF CH3CH2OH AND CH3C*OOH BY Cl. kluyveri Experiment 1 COMPOUND MM CTS./MIN./MM TOTAL CT$./MIN. Before growth Ethanol ca. 1. 1 .... Acetic acid ' 0.830 18,900 300 15,700 Carbon dioxide ca. 0.2 .... After growth Acetic acid 0.395 7330 150 2895 Butyric acid 0.196 18,200 300 3570 Caproic acid 0.257 24,500 500 6300 Carbon dioxide 0.185 26 50 5 Ethanol 0.217 260 = 50 74 Non-volatile cpds. 193 Percentage recovery of C'4.......................................... 83 traces of salts of Ca, Mn and Mo, distilled water. In some experiments sodium carbonate (0.025 g. per 100 ml.) was added as a sterile solution after autoclaving the medium. Oxygen was removed by means of either a pyrogallol-potassium carbonate or an Oxsorbent seal. The cultures were incubated at 32-35° until growth ceased before being analyzed. Results.-When Cl. kluyveri was allowed to grow in a medium containing approximately equivalent amounts of ethanol and synthetic carboxyl- labeled sodium acetate, radioactive butyric and caproic acids were formed (table 1). The isotope was proved to be present in these acids, rather' than in some associated compound, by establishing the constancy of the specific activities of the barium salts prepared from different fractions of a Duclaux distillation (table 2). A little C14 was also found in ethanol and unidenti- fied non-volatile compounds, but no significant amount was present in carbon dioxide. .It should be noted that there is no net production of Downloaded by guest on September 25, 2021 VOL. 31, 1945 BACTERIOLOGY: BARKER, ETAL. 375 carbon dioxide in thit fermentation. The recovery of C14 in all forms after growth was about 83 per cent of that initially added as acetic acid. A particularly significant fact revealed by this experiment is the de- crease in the molar activity of acetic acid during the fermentation. At the beginning of the experiment the activity expressed in cts./min./mM was 18.9 X 103 while at the end the value was 7.3 X 103. The simplest and most likely explanation for this reduction in activity is the oxidation of ethanol to inactive acetic acid or some closely related compound in equi- librium with it. This would cause a dilution of the labeled acetic acid. TABLE 2 SPECIFIC ACTIVITIES OF BARIUM SALTS OF BUTYRIC AND CAPROIC ACIDS PREPARED FROM DUCLAUx DISTILLATIONS Experiment 1 (total volume = 110 ml.) FRACTION CTS./MIN./MG. OF Ba SALT Butyric acid 0-20 ml. 47.5 20-40 ml. 47.6 40-110 ml. 46.4 Caproic acid 0-20 ml. 63.7 20-110 ml. 62.2 Another possible explanation for the decrease in activity of acetic acid is that it is in chemical and isotopic equilibrium with the higher fatty acids formed from it and ethanol. This was tested by two experiments in one of which butyric acid labeled in the carboxyl group was added at the be- ginning of the fermentation; in the second experiment butyric acid labeled on all four carbon atoms was used. In the experiment with carboxyl- labeled butyric acid (table 4), no C14 could be detected in the final acetic acid, thus indicating that no exchange occurred between the carboxyl groups of butyric acid and acetic acid. In the second experiment with com- pletely labeled butyric acid, a little C14 was recovered in the final acetic acid but it was less than 9 per cent of the amount to be expected if butyric and acetic acids were in isotopic equilibrium, and even this small effect may have been due to a slight contamination of the original butyric acid by labeled acetic acid. An exchange of C'4 between acetic acid and the higher fatty acids can therefore be excluded as an explanation for the observed decrease in activity of acetic acid. A third possible explanation for this effect is an exchange of C14 between ethanol and acetic acid as a result of reactions involving acetaldehyde or a similar compound as an intermediate. If such a reaction occurs, the residual ethanol should have the same molar activity as the acetic acid. Actually, the activity of the alcohol is of a lower order of magnitude Downloaded by guest on September 25, 2021 376 BA CTERIOLOG Y: BARKER, ET AL. PROC. N4. A. S. (table 1). Therefore an exchange of C14 between acetic acid and ethanol is not consistent with the observed results. Whatever the actual mechanism of the dilution of the active acetic acid, the magnitude of the effect is about what would be expected if all the ethanol is oxidized to acetic acid while the latter is being converted to higher fatty acids. To calculate the expected decrease of acetic acid activity on this basis, let us assume that (1) the fermentation proceeds in two successive steps represented by equations (1) and (3), and that during the fermentation all the ethanol is first converted to acetic acid or some compound in isotopic equilibrium with it. In step 1, the formation of butyric acid from ethanol and acetic acid, let x = the amount of C14 present in acetic acid at any time, xo = the initial C14, x, = the C14 at the end of step 1, V = the amount of acetic acid present at any time, Vo = the initial acetic acid, and Vf = the final acetic acid. Now during step 1, when a small amount (AV) of alcohol is oxidized to inactive acetic acid, the re- moval of active acetic acid by conversion to butyric acid will be equal to 2 A V. The loss of C14 fromi acetic acid is therefore -AX = -2AV/V- AV-x. (4) In the limit as A V approaches zero dxlx = 2d V/V. (4a) Integrating between the limits of VO and V,, and xo and xi and changing to log,o we get log xl/xO = 2 log Vf/ Vo (5) or Xi = Xo(V/ o) 2. (5a) In step 2 (equation 3), the conversion of alcohol and butyric acid to 'caproic acid, there is no change in the total quantity of acetic acid; V, is therefore a constant. C14 will nevertheless be lost from acetic acid if, as is assumed, it is an intermediate in the utilization of ethanol. When a small amount of alcohol (AA) is used, the loss of C14 from acetic acid is -Ax = AA/(V, + 4A)*x. (6) In the limit -dx/x = dA/Vf. (6a) Integrating between the limits xi and xf, and 0 and A,, where A, is the total amount of alcohol used in step 2 ln xl/xf = 2.3 log xl/xf = A,/ Vf (7) or log xf = log x' - Af/2.3Vf (7a) Downloaded by guest on September 25, 2021 VOL.
Recommended publications
  • Effect of Propionic Acid on Fatty Acid Oxidation and U Reagenesis
    Pediat. Res. 10: 683- 686 (1976) Fatty degeneration propionic acid hyperammonemia propionic acidemia liver ureagenesls Effect of Propionic Acid on Fatty Acid Oxidation and U reagenesis ALLEN M. GLASGOW(23) AND H. PET ER C HASE UniversilY of Colorado Medical Celller, B. F. SlOlillsky LaboralOries , Denver, Colorado, USA Extract phosphate-buffered salin e, harvested with a brief treatment wi th tryps in- EDTA, washed twice with ph os ph ate-buffered saline, and Propionic acid significantly inhibited "CO z production from then suspended in ph os ph ate-buffe red saline (145 m M N a, 4.15 [I-"ejpalmitate at a concentration of 10 11 M in control fibroblasts m M K, 140 m M c/, 9.36 m M PO" pH 7.4) . I n mos t cases the cells and 100 11M in methyl malonic fibroblasts. This inhibition was we re incubated in 3 ml phosph ate-bu ffered sa lin e cont aining 0.5 similar to that produced by 4-pentenoic acid. Methylmalonic acid I1Ci ll-I4Cj palm it ate (19), final concentration approximately 3 11M also inhibited ' 'C0 2 production from [V 'ejpalmitate, but only at a added in 10 II I hexane. Increasing the amount of hexane to 100 II I concentration of I mM in control cells and 5 mM in methyl malonic did not impair palmit ate ox id ation. In two experiments (Fig. 3) the cells. fibroblasts were in cub ated in 3 ml calcium-free Krebs-Ringer Propionic acid (5 mM) also inhibited ureagenesis in rat liver phosphate buffer (2) co nt ain in g 5 g/ 100 ml essent iall y fatty ac id slices when ammonia was the substrate but not with aspartate and free bovine se rum albumin (20), I mM pa lm itate, and the same citrulline as substrates.
    [Show full text]
  • Draft SANCO 10387 V.12 CAS No Endringer Draft Vs. Dir 2004/4/EC Endringer Draft CAC/RCP 36 - 1987 Dir 2004/4/EC Vs
    Draft SANCO 10387 v.12 CAS No Endringer draft vs. Dir 2004/4/EC Endringer draft CAC/RCP 36 - 1987 dir 2004/4/EC vs. CAC/RCP 36 - 1987 Acetic acid (ethanoic acid; vinegar acid; methane carboxylic 64-19-7 Redigert Acetic acid Acetic acid acid) Acetic anhydride (ethanoic anhydride) 108-24-7 Acetic anhydride (ethanoic anhydride Acetic anhydride (ethanoic anhydride Acid oils and fatty acid distillates — from vegetable oils and fats --- Acid oils and fatty acid distillates — from vegetable oils and fats Endret Acid oils and fatty acid distillates - from animal, marine and and/or mixtures thereof and animal and marine fats and oils and/or mixtures thereof and animal and marine fats and oils vegetable fats and oils Acetone (dimethylketone; 2-propanone) 67-64-1 Acetone (dimethylketone; 2-propanone) Acetone (dimethylketone; 2-propanone) Ammonium hydroxide (ammonium hydrate; ammonia solution; 1336-21-6 Ammonium hydroxide (ammonium hydrate; ammonia solution; Ammonium hydroxide (ammonium hydrate; ammonia solution; aqua ammonia) aqua ammonia) aqua ammonia) Ammonium polyphosphate 68333-79-9 Ammonium polyphosphate Ammonium polyphosphate and 10124-31- 9 Animal, marine and vegetable and hydrogenated oils and fats --- Endret Animal, marine and vegetable and hydrogenated oils and fats Animal, marine and vegetable and hydrogenated oils and fats according to the MEPC.2/Circ. of the IMO. (other than cashew shell nut and crude tall oil) according to the MEPC of the IMO. Benzyl alcohol (pharmaceutical and reagent grades only) 100-51-6 Redigert Benzyl alcohol (pharmaceutical
    [Show full text]
  • MONTHLY NEWSLETTER May 2021
    MONTHLY NEWSLETTER May 2021 By: Kevin Burgoon, Ph.D., Senior Nutritionist Purina® Honor® Show Technical Solutions SOURCES: Soybeans, corn, sunflower seed/oil, eggs, HOT TOPIC OF THE MONTH fishmeal, rice bran There is much buzz around Omega fatty acids these days and how they contribute to animal nutrition. These BENEFITS: fatty acids are not new, but they have become of GLA – anti-inflammatory increasing importance. This issue will explore fatty acid CLA – improved leanness and hardness of fat cover contribution both Omegas and Medium Chained Fatty Acids (MCFA). GLA – anti-inflammatory WHAT IS ESSENTIAL? NEGATIVES: You may have heard the term essential as it pertains to Linoleic, AA, and DGLA can be pro-inflammatory nutrition. Essential Fatty Acids, Essential Amino Acids, and more. The term essential simply means that the OMEGA 9 FATTY ACIDS: animal’s metabolism cannot synthesize those nutrients Anti-inflammatory or cannot synthesize them in sufficient quantities to meet the animal’s requirements. Therefore, these nutrients Can be pro-inflammatory (depending upon ratios) MUST be included in the animal’s diet. Improved insulin sensitivity WHAT ARE OMEGA FATTY ACIDS? SOURCES: Soybean oil, canola oil, fish oil, grains The indication OMEGA refers to position of the final double bond from the Omega or the tail end in the IMPORTANT: The proper balance of Omega fatty acids chemical structure. Omega 3 is 3 carbons from the tail has been identified as increasingly important to prevent end. Omega 6 refers to 6 carbons and Omega 9, 9 negative effects. carbons from the tail end. The Omega 3 and 6 fatty acids are polyunsaturated, while Omega 9 is monounsaturated.
    [Show full text]
  • Fatty Acids: Essential…Therapeutic
    Volume 3, No.2 May/June 2000 A CONCISE UPDATE OF IMPORTANT ISSUES CONCERNING NATURAL HEALTH INGREDIENTS Written and Edited By: Thomas G. Guilliams Ph.D. FATTY ACIDS: Essential...Therapeutic Few things have been as confusing to both patient and health care provider as the issue of fats and oils. Of all the essential nutrients required for optimal health, fatty acids have not only been forgotten they have been considered hazardous. Health has somehow been equated with “low-fat” or “fat-free” for so long, to suggest that fats could be essential or even therapeutic is to risk credibility. We hope to give a view of fats that is both balanced and scientific. This review will cover the basics of most fats that will be encountered in dietary or supplemental protocols. Recommendations to view essential fatty acids in a similar fashion as essential vitamins and minerals will be combined with therapeutic protocols for conditions ranging from cardiovascular disease, skin conditions, diabetes, nerve related disorders, retinal disorders and more. A complete restoration of health cannot be accomplished until there is a restoration of fatty acid nutritional information among health care professionals and their patients. Fats- What are they? Dietary fats come to us from a variety of sources, but primarily in the form of triglycerides. That is, three fatty acid molecules connected by a glycerol backbone (see fatty acid primer page 3 for diagram). These fatty acids are then used as energy by our cells or modified into phospholipids to be used as cell or organelle membranes. Some fatty acids are used in lipoprotein molecules to shuttle cholesterol and fats to and from cells, and fats may also be stored for later use.
    [Show full text]
  • Relationship Between Dietary Intake of Fatty Acids and Disease Activity in Pediatric Inflammatory Bowel Disease Patients
    Relationship between Dietary Intake of Fatty Acids and Disease Activity in Pediatric Inflammatory Bowel Disease Patients A thesis submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Master of Science in the Department of Nutrition of the College of Allied Health Sciences by Michael R. Ciresi B.S. The Ohio State University June 2008 Committee Chair: Grace Falciglia, Ph.D. Abstract Background. Crohn’s disease (CD) and ulcerative colitis (UC), collectively known as inflammatory bowel disease (IBD), are chronic illnesses that affect predominately the gastrointestinal tract. The pathogenesis and etiology remain unclear but the importance of environmental factors, in particular diet, is evidenced by the increased incidence rates of the recent decades that genetic inheritance cannot account for. In particular, the quantity of fatty acid consumption has been consistently linked with IBD risk. While several studies have investigated the connections between diet, etiology, signs and symptoms associated with IBD, very few have explored the relationship between disease state and specific fatty acid intake in the pediatric IBD population. Methods. In this cross-sectional study, 100 pediatric patients from Cincinnati Children’s Hospital and the Hospital for Sick Children in Toronto with diagnosed IBD (73 with Crohn’s disease (CD) and 27 with ulcerative colitis (UC)) were included. Three-day diet records were collected from the patients for the assessment of their dietary intake. The abbreviated Pediatric Crohn’s Disease Activity Index (PCDAI), the abbreviated Ulcerative Colitis Activity Index (PUCAI), and markers of inflammation (lipopolysaccharide binding protein (LBP) and S100A12) were used to assess disease severity.
    [Show full text]
  • Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva
    REVIEW ARTICLE Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva Philip N. Patsalos, FRCPath, PhD*† and Dave J. Berry, FRCPath, PhD† INTRODUCTION Abstract: Blood (serum/plasma) antiepileptic drug (AED) therapeu- Measuring antiepileptic drugs (AEDs) in serum or tic drug monitoring (TDM) has proven to be an invaluable surrogate plasma as an aid to personalizing drug therapy is now a well- marker for individualizing and optimizing the drug management of established practice in the treatment of epilepsy, and guidelines patients with epilepsy. Since 1989, there has been an exponential are published that indicate the particular features of epilepsy and increase in AEDs with 23 currently licensed for clinical use, and the properties of AEDs that make the practice so beneficial.1 recently, there has been renewed and extensive interest in the use of The goal of AED therapeutic drug monitoring (TDM) is to saliva as an alternative matrix for AED TDM. The advantages of saliva ’ fl optimize a patient s clinical outcome by supporting the man- include the fact that for many AEDs it re ects the free (pharmacolog- agement of their medication regimen with the assistance of ically active) concentration in serum; it is readily sampled, can be measured drug concentrations/levels. The reason why TDM sampled repetitively, and sampling is noninvasive; does not require the has emerged as an important adjunct to treatment with the expertise of a phlebotomist; and is preferred by many patients, AEDs arises from the fact that for an individual patient
    [Show full text]
  • A Facile Profiling Method of Short Chain Fatty Acids Using Liquid
    H OH metabolites OH Article A Facile Profiling Method of Short Chain Fatty Acids Using Liquid Chromatography-Mass Spectrometry Ha Eun Song 1, Hyo Yeong Lee 1, Su Jung Kim 1, Sung Hoon Back 2 and Hyun Ju Yoo 1,* 1 Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea 2 School of Biological Sciences, University of Ulsan, Ulsan 44610, Korea * Correspondence: [email protected]; Tel.: +82-02-3010-4029 Received: 27 June 2019; Accepted: 23 August 2019; Published: 28 August 2019 Abstract: Short chain fatty acids (SCFAs) are the main products of dietary fibers that are not digested by the human body, and they have been shown to affect human metabolism and inflammation. The amount of SCFAs in the body is related to many human diseases, and studies have focused on elucidating their roles and target molecules in both metabolic and immune responses. Thus, the quantitation of SCFAs in biological samples becomes crucial in understanding their important roles in the human body. Herein, a facile profiling method of SCFAs using liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and then applied to biological samples. C2-C6 SCFAs were derivatized while using 4-acetamido-7-mercapto-2,1,3-benzoxadiazole for 5 min. at room temperature prior to LC-MS/MS analysis, and characteristic fragmentation patterns and increased hydrophobicity after chemical derivatization enabled specific discrimination among 12 SCFAs. Derivatization was fast and reliable, and the reaction products were stable for a week at 4 ◦C.
    [Show full text]
  • Official Journal of the European Communities on the Hygiene Of
    No L 21 /42 EN Official Journal of the European Communities 27 . 1 . 96 COMMISSION DIRECTIVE 96/3/EC of 26 January 1 996 granting a derogation from certain provisions of Council Directive 93/43/EEC on the hygiene of foodstuffs as regards the transport of bulk liquid oils and fats by sea (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, whereas the measures provided for in this Directive are in compliance with the opinion of the Standing Having regard to the Treaty establishing the European Committee for Foodstuffs, Community, Having regard to Council Directive 93/43/EEC of 14 June 1993 on the hygiene of foodstuffs ('), and in parti­ HAS ADOPTED THIS DIRECTIVE : cular Article 3 (3) thereof, Whereas information shows that the application of the second subparagraph of paragraph 2 of Chapter IV of the Article 1 Annex to Directive 93/43/EEC relating to the transport of bulk foodstuffs in liquid, granulate or powdered form in This Directive derogates from the second subparagraph of receptacles and/or containers/tankers reserved for the paragraph 2 of Chapter IV of the Annex to Directive transport of foodstuffs, is not practical and imposes an 93/43/EEC and lays down equivalent conditions to ensure unduly onerous burden on food business when applied to the protection of public health and the safety and whole­ the transport in sea-going vessels of liquid oils and fats someness of the foodstuffs concerned . intended for, or likely to be used for, human consump­ tion ; Article 2 Whereas, however, it is necessary to ensure that the granting of a derogation provides equivalent protection to public health, by attaching conditions to the terms of 1 .
    [Show full text]
  • Fats and Fatty Acid in Human Nutrition
    ISSN 0254-4725 91 FAO Fats and fatty acids FOOD AND NUTRITION PAPER in human nutrition Report of an expert consultation 91 Fats and fatty acids in human nutrition − Report of an expert consultation Knowledge of the role of fatty acids in determining health and nutritional well-being has expanded dramatically in the past 15 years. In November 2008, an international consultation of experts was convened to consider recent scientific developments, particularly with respect to the role of fatty acids in neonatal and infant growth and development, health maintenance, the prevention of cardiovascular disease, diabetes, cancers and age-related functional decline. This report will be a useful reference for nutrition scientists, medical researchers, designers of public health interventions and food producers. ISBN 978-92-5-106733-8 ISSN 0254-4725 9 7 8 9 2 5 1 0 6 7 3 3 8 Food and Agriculture I1953E/1/11.10 Organization of FAO the United Nations FAO Fats and fatty acids FOOD AND NUTRITION in human nutrition PAPER Report of an expert consultation 91 10 − 14 November 2008 Geneva FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 2010 The designations employed and the presentation of material in this information product do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations (FAO) concerning the legal or development status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or products of manufacturers, whether or not these have been patented, does not imply that these have been endorsed or recommended by FAO in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • Optimized and Scalable Synthesis of Magnetic Nanoparticles for RNA
    www.nature.com/scientificreports OPEN Optimized and scalable synthesis of magnetic nanoparticles for RNA extraction in response to developing countries’ needs in the detection and control of SARS‑CoV‑2 Julio C. Chacón‑Torres1*, C. Reinoso1, Daniela G. Navas‑León2, Sarah Briceño1 & Gema González1* Ecuador is one of the most afected countries, with the coronavirus disease 2019 (COVID‑19) infection, in Latin America derived from an ongoing economic crisis. One of the most important methods for COVID‑19 detection is the use of techniques such as real time RT‑PCR based on a previous extraction/ purifcation of RNA procedure from nasopharyngeal cells using functionalized magnetic nanoparticles (MNP). This technique allows the processing of ~ 10,000 tests per day in private companies and around hundreds per day at local Universities guaranteeing to reach a wide range of the population. However, the main drawback of this method is the need for specialized MNP with a strong negative charge for the viral RNA extraction to detect the existence of the SARS‑CoV‑2 virus. Here we present a simplifed low cost method to produce 10 g of nanoparticles in 100 mL of solution that was scaled to one litter by parallelizing the process 10 times in just two days and allowing for the possibility of making ~ 50,000 COVID‑19 tests. This communication helps in reducing the cost of acquiring MNP for diverse biomolecular applications supporting developing country budgets constraints and chemical availability specially during the COVID‑19 International Health Emergency. Te prevailing pandemic originated from the unusual coronavirus SARS-CoV-2 that causes the COVID-19 infectious disease has been striking the medical health system world wide due to its rapid propagation person-to- person1–4.
    [Show full text]
  • Reactive Extraction of Caproic Acid Using Tri-N- Butyl Phosphate (TBP) in Non Toxic Diluents
    International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.11 No.07, pp 56-62, 2018 Reactive Extraction of Caproic Acid using Tri-n- Butyl Phosphate (TBP) in Non Toxic Diluents Ashwani Kumar Rathore1, Deepak Srivastava2, 3 3 Kailas L Wasewar , and Diwakar Z Shende * 1Department of Chemical Engineering, School of Chemical Technology, H B Technical University (Formerly H B Technological Institute), Kanpur, India. 2Department of Plastic Technology, School of Chemical Technology, H B Technical University (Formerly H B Technological Institute), Kanpur, India 3Department of Chemical Engineering, VNIT Nagpur, India. Abstract : The present paper deals with the study of reactive extraction of caproic acid using tri-n-butyl phosphate in non-toxic diluents (oils obtain from sunflower, soybean, and rice bran) in different proportions and combinations of extractant and the non-toxic diluents. Results were presented in terms of distribution coefficients, loading ratio, degree of extraction, equilibrium complexation constants and the kinetics of reaction involved. The data obtained were found to be useful for process engineers to efficiently design reactive extraction process for the recovery of caproic acid by thorough understanding of the equilibrium characteristics. Also, the problem of toxicity in reactive extraction could be reduced by using the natural non-toxic diluents with the extractant. Keywords : Reactive extraction, TBP, Nontoxic diluent, Caproicacid, Toxicity, batch process. Introduction Reactive extraction is a showing a lot of promise for the recovery of carboxylic acid with respect to other processes such as distillation(not suitable for low concentration), electro dialysis (high cost of membrane and fouling)and other conventional precipitation processes( by product disposal).
    [Show full text]
  • Formic Acid Acetic Acid Propionic Acid Butyric Acid Valeric Acid Caproic
    Organic Acids: Formic acid Citric acid Acetic acid Malic acid Propionic acid Benzoic acid Butyric acid Tartaric acid Valeric acid Caproic acid Oxalic acid Lactic acid Organic Bases: Pyridine Imidazole (solid) Benzimidazole Aniline TEA (tri-ethyl amine) Histidine Nitroaniline Imidazole (dissolved) Amino bases/ Nucleotides ממסים אורגניים (מכילים קשר פחמן-מימן): :(Organic Solvents (contains carbon-hydrogen bond Xylene DMF Hexane Parafine oil Ethylacetate Formamide IPA Piperidine Trizol/Trireagent Butanol SDS (solid) Acetone PMSF (Phenylmethanesulfonyl fluoride) Methanol Tween PFA RNA / DNA (kit parts that contains thioisocyanate) Toluene BME (beta mercaptoethanol) DMSO Ethylenglycol Ethanol Halogenated Organic Solvents (contains F, Cl, Br, I): ממסים אורגניים הלוגניים (מכילים F, Cl, Br, I) Chloroform (CHCl3) Methylene chloride Vinyl chloride Tetrafluoroethylene (CF2 =CF2) Trichloroethylene (CHCl=CCl2) Bromoethane Tert-Butyl bromide חומרים אנאורגניים (חומרים שהם לא חומצה/בסיס אנאורגני) Inorganic Materials (are not inorganic acid/base) LiCl Salts (such as MgCl2, CaCl) Hydrogen peroxide (H2O2) Metals (Cu, Pb, Na etc.) Ammonium thiocyanate (NH4SCN) Sodium Azide (NaN3) Ammonium azide (NH4N3) בסיסים אנאורגניים :Inorganic Bases NH3 NaOH NH4OH Ba(OH)2 NaOH (dissolved) Ca(OH)2 KOH (dissolved) CaCO3 KOH חומצות אנאורגניות: :Inorganic Acids Boric acid (H3BO3) Hydrochloric acid (HCl) Hydrofluoric acid (HF) Nitric acid (HNO3) Hydrobromic acid (HBr) Phosphoric acid (H3PO4) Perchloric acid (HClO4) Sulfuric acid (H2SO4) Hydroiodic acid (HI) Cytotoxic materials:
    [Show full text]